SE453537B - Sett att framstella blandningar innehallande partiklar av lipoidlosliga substanser och vid dessa bundna biologiskt aktiva substanser - Google Patents
Sett att framstella blandningar innehallande partiklar av lipoidlosliga substanser och vid dessa bundna biologiskt aktiva substanserInfo
- Publication number
- SE453537B SE453537B SE8009068A SE8009068A SE453537B SE 453537 B SE453537 B SE 453537B SE 8009068 A SE8009068 A SE 8009068A SE 8009068 A SE8009068 A SE 8009068A SE 453537 B SE453537 B SE 453537B
- Authority
- SE
- Sweden
- Prior art keywords
- particles
- biologically active
- lipoid
- substances
- solution
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/586—Liposomes, microcapsules or cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Dispersion Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- External Artificial Organs (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU79HU299A HU184141B (en) | 1979-12-27 | 1979-12-27 | Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8009068L SE8009068L (sv) | 1981-06-28 |
SE453537B true SE453537B (sv) | 1988-02-08 |
Family
ID=10997378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8009068A SE453537B (sv) | 1979-12-27 | 1980-12-22 | Sett att framstella blandningar innehallande partiklar av lipoidlosliga substanser och vid dessa bundna biologiskt aktiva substanser |
Country Status (21)
Country | Link |
---|---|
US (1) | US4396630A (de) |
JP (1) | JPS57112334A (de) |
BE (1) | BE886884A (de) |
CA (1) | CA1165237A (de) |
CH (1) | CH655246A5 (de) |
CS (1) | CS241478B2 (de) |
DD (1) | DD158738A5 (de) |
DE (1) | DE3048815A1 (de) |
DK (1) | DK160288C (de) |
ES (1) | ES498048A0 (de) |
FR (1) | FR2472386B1 (de) |
GB (1) | GB2066203B (de) |
HU (1) | HU184141B (de) |
IT (1) | IT1150073B (de) |
NL (1) | NL8007041A (de) |
PL (1) | PL228755A1 (de) |
PT (1) | PT72261B (de) |
RO (1) | RO81371A (de) |
SE (1) | SE453537B (de) |
SU (1) | SU1487802A3 (de) |
YU (1) | YU44413B (de) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4598051A (en) * | 1980-03-12 | 1986-07-01 | The Regents Of The University Of California | Liposome conjugates and diagnostic methods therewith |
US4806466A (en) * | 1981-10-29 | 1989-02-21 | The Regents Of The University Of California | Cell agglutination reagent comprising conjugates of antibody covalently bound to liposomes |
FR2521565B1 (fr) * | 1982-02-17 | 1985-07-05 | Dior Sa Parfums Christian | Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees |
DD247570A3 (de) * | 1983-01-14 | 1987-07-15 | Univ Berlin Humboldt | Vesikulaeres trenn-, fuell- und traegermaterial |
US4515736A (en) * | 1983-05-12 | 1985-05-07 | The Regents Of The University Of California | Method for encapsulating materials into liposomes |
US5059591B1 (en) * | 1983-05-26 | 2000-04-25 | Liposome Co Inc | Drug preparations of reduced toxicity |
US4708861A (en) * | 1984-02-15 | 1987-11-24 | The Liposome Company, Inc. | Liposome-gel compositions |
US5916588A (en) * | 1984-04-12 | 1999-06-29 | The Liposome Company, Inc. | Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use |
US6090406A (en) * | 1984-04-12 | 2000-07-18 | The Liposome Company, Inc. | Potentiation of immune responses with liposomal adjuvants |
GB2160312B (en) * | 1984-04-13 | 1987-09-16 | South African Inventions | Adjuvant for immunisation |
PT78628B (en) * | 1984-05-02 | 1986-06-18 | Liposome Co Inc | Pharmaceutical composition with reduced toxicity |
US4619904A (en) * | 1984-10-29 | 1986-10-28 | General Electric Company | Agglutinating immunoassay using protein-coated liquid droplets |
US4857319A (en) * | 1985-01-11 | 1989-08-15 | The Regents Of The University Of California | Method for preserving liposomes |
ATE68686T1 (de) * | 1985-10-31 | 1991-11-15 | Kv Pharm Co | System zum freigeben von stoffen in der vagina. |
US5266329A (en) * | 1985-10-31 | 1993-11-30 | Kv Pharmaceutical Company | Vaginal delivery system |
US4790987A (en) * | 1985-11-15 | 1988-12-13 | Research Corporation | Viral glycoprotein subunit vaccine |
CA1338736C (fr) * | 1986-12-05 | 1996-11-26 | Roger Baurain | Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation |
US5688519A (en) * | 1987-04-06 | 1997-11-18 | Leonard; Robert J. | Flash-flow fused medicinal implants |
US4748024A (en) * | 1987-04-06 | 1988-05-31 | Endocon, Inc. | Flash flow fused medicinal implants |
WO1990001948A1 (en) * | 1988-08-25 | 1990-03-08 | The Liposome Company, Inc. | Influenza vaccine and novel adjuvants |
EP0374296B1 (de) * | 1988-12-22 | 1995-02-01 | Dade International Inc. | Lipohaptene und Verwendung trägergebundener Lipohaptene im Immuntest |
US5100662A (en) * | 1989-08-23 | 1992-03-31 | The Liposome Company, Inc. | Steroidal liposomes exhibiting enhanced stability |
JPH07113641B2 (ja) * | 1989-11-17 | 1995-12-06 | 積水化学工業株式会社 | 梅毒診断試薬の製造方法 |
NL9000207A (de) * | 1990-01-29 | 1991-08-16 | Duphar Int Res | |
US5709879A (en) * | 1990-06-29 | 1998-01-20 | Chiron Corporation | Vaccine compositions containing liposomes |
ATE185486T1 (de) * | 1990-06-29 | 1999-10-15 | Chiron Corp | Liposomen enthaltende impfstoffzusammensetzungen |
IE912535A1 (en) * | 1990-07-27 | 1992-01-29 | Res Dev Foundation | Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens |
WO1992004887A1 (en) * | 1990-09-25 | 1992-04-02 | Kyowa Hakko Kogyo Co., Ltd. | Induction of cytotoxic t cell |
US6048531A (en) * | 1991-04-15 | 2000-04-11 | Albany Medical College | Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies |
US5336507A (en) * | 1992-12-11 | 1994-08-09 | Sterling Winthrop Inc. | Use of charged phospholipids to reduce nanoparticle aggregation |
GB9320668D0 (en) * | 1993-10-07 | 1993-11-24 | Secr Defence | Liposomes containing particulare materials |
AUPM500494A0 (en) * | 1994-04-12 | 1994-05-05 | Minister For Agriculture & Rural Affairs For The State Of New South Wales, The | Composition for use in increasing mucosal immunity |
BR0115260A (pt) * | 2000-11-09 | 2005-08-16 | Neopharm Inc | Complexos de sn-38 com lipìdeos e seus usos no tratamento de doenças |
WO2003030864A1 (en) * | 2001-05-29 | 2003-04-17 | Neopharm, Inc. | Liposomal formulation of irinotecan |
WO2003075889A1 (en) * | 2002-03-05 | 2003-09-18 | Transave, Inc. | An inhalation system for prevention and treatment of intracellular infections |
US20060030578A1 (en) * | 2002-08-20 | 2006-02-09 | Neopharm, Inc. | Pharmaceutically active lipid based formulation of irinotecan |
WO2004035032A2 (en) * | 2002-08-20 | 2004-04-29 | Neopharm, Inc. | Pharmaceutical formulations of camptothecine derivatives |
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
EP1581236B1 (de) * | 2002-10-29 | 2013-10-16 | Insmed Incorporated | Verzögerte freisetzung von anti-infektionsmitteln |
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
KR100651728B1 (ko) * | 2004-11-10 | 2006-12-06 | 한국전자통신연구원 | 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법 |
WO2006090816A1 (ja) * | 2005-02-25 | 2006-08-31 | Mie University | リポソームワクチンの作製法 |
ES2594368T3 (es) | 2005-12-08 | 2016-12-19 | Insmed Incorporated | Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares |
WO2008137717A1 (en) | 2007-05-04 | 2008-11-13 | Transave, Inc. | Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
HRP20220158T1 (hr) | 2012-05-21 | 2022-04-15 | Insmed Incorporated | Sustavi za liječenje plućnih infekcija |
RU2018135921A (ru) | 2012-11-29 | 2019-02-05 | Инсмед Инкорпорейтед | Стабилизированные составы ванкомицина |
PL3466432T3 (pl) | 2014-05-15 | 2021-02-08 | Insmed Incorporated | Sposoby leczenia zakażeń płuc niegruźliczymi mykobakteriami |
US11571386B2 (en) | 2018-03-30 | 2023-02-07 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3265629A (en) * | 1958-12-22 | 1966-08-09 | Ncr Co | Coating by phase separation |
DE2249552A1 (de) * | 1971-10-12 | 1973-05-30 | Inchema S A | Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen |
GB1502774A (en) * | 1974-06-25 | 1978-03-01 | Nat Res Dev | Immunological preparations |
JPS5126213A (ja) * | 1974-08-21 | 1976-03-04 | Tanabe Seiyaku Co | Johoseibiryushiseizaino seiho |
GB1564500A (en) * | 1975-09-29 | 1980-04-10 | Wellcome Found | Biological preparations |
GB1523965A (en) * | 1976-03-19 | 1978-09-06 | Ici Ltd | Pharmaceutical compositions containing steroids |
GB1575343A (en) * | 1977-05-10 | 1980-09-17 | Ici Ltd | Method for preparing liposome compositions containing biologically active compounds |
IT1110989B (it) * | 1979-01-19 | 1986-01-13 | Erba Farmitalia | Forme farmaceutiche costitutite da liposomi e procedimenti relativi |
FR2416008A1 (fr) * | 1978-02-02 | 1979-08-31 | Oreal | Lyophilisats de liposomes |
US4235871A (en) * | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
JPS55118415A (en) * | 1979-02-28 | 1980-09-11 | Pii Papahadojiyopo Dometoriosu | Method of encapsulating biologically active substance in lipoid cell |
-
1979
- 1979-12-27 HU HU79HU299A patent/HU184141B/hu unknown
-
1980
- 1980-12-12 CH CH9166/80A patent/CH655246A5/de not_active IP Right Cessation
- 1980-12-19 US US06/218,126 patent/US4396630A/en not_active Expired - Fee Related
- 1980-12-22 ES ES498048A patent/ES498048A0/es active Granted
- 1980-12-22 PT PT72261A patent/PT72261B/pt unknown
- 1980-12-22 SE SE8009068A patent/SE453537B/sv not_active IP Right Cessation
- 1980-12-23 DK DK552280A patent/DK160288C/da active
- 1980-12-23 CS CS809246A patent/CS241478B2/cs unknown
- 1980-12-23 PL PL22875580A patent/PL228755A1/xx unknown
- 1980-12-23 GB GB804281A patent/GB2066203B/en not_active Expired
- 1980-12-23 DE DE19803048815 patent/DE3048815A1/de active Granted
- 1980-12-24 IT IT26950/80A patent/IT1150073B/it active
- 1980-12-24 NL NL8007041A patent/NL8007041A/nl not_active Application Discontinuation
- 1980-12-24 FR FR8027496A patent/FR2472386B1/fr not_active Expired
- 1980-12-24 CA CA000367565A patent/CA1165237A/en not_active Expired
- 1980-12-25 RO RO80102952A patent/RO81371A/ro unknown
- 1980-12-26 JP JP55184157A patent/JPS57112334A/ja active Granted
- 1980-12-26 SU SU803220898A patent/SU1487802A3/ru active
- 1980-12-26 YU YU3290/80A patent/YU44413B/xx unknown
- 1980-12-29 BE BE0/203337A patent/BE886884A/fr not_active IP Right Cessation
-
1981
- 1981-01-30 DD DD81227326A patent/DD158738A5/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES8201316A1 (es) | 1981-12-16 |
JPH0314814B2 (de) | 1991-02-27 |
GB2066203B (en) | 1984-01-11 |
FR2472386A1 (de) | 1981-07-03 |
HU184141B (en) | 1984-07-30 |
YU44413B (en) | 1990-08-31 |
GB2066203A (en) | 1981-07-08 |
RO81371B (ro) | 1983-11-02 |
CA1165237A (en) | 1984-04-10 |
JPS57112334A (en) | 1982-07-13 |
DK160288C (da) | 1991-08-05 |
DD158738A5 (de) | 1983-02-02 |
PT72261A (en) | 1981-01-01 |
PL228755A1 (de) | 1982-02-15 |
US4396630A (en) | 1983-08-02 |
DK552280A (da) | 1981-06-28 |
BE886884A (fr) | 1981-06-29 |
ES498048A0 (es) | 1981-12-16 |
IT1150073B (it) | 1986-12-10 |
SU1487802A3 (ru) | 1989-06-15 |
RO81371A (ro) | 1984-04-02 |
DE3048815A1 (de) | 1981-09-10 |
SE8009068L (sv) | 1981-06-28 |
DK160288B (da) | 1991-02-25 |
NL8007041A (nl) | 1981-07-16 |
YU329080A (en) | 1984-04-30 |
CS924680A2 (en) | 1985-07-16 |
PT72261B (en) | 1981-11-05 |
FR2472386B1 (de) | 1985-08-23 |
IT8026950A0 (it) | 1980-12-24 |
CH655246A5 (de) | 1986-04-15 |
CS241478B2 (en) | 1986-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE453537B (sv) | Sett att framstella blandningar innehallande partiklar av lipoidlosliga substanser och vid dessa bundna biologiskt aktiva substanser | |
DE60121136T2 (de) | Proteasom-influenzavirus-impfstoffzusammensetzung | |
WO1995007290A1 (en) | Method for purifying egg yolk immunoglobulins | |
CN105920599A (zh) | 以阳离子脂质体dotap为佐剂的疫苗及其制备方法 | |
Alexander et al. | Production of types a, b, c, d, e and f H. influenzae antibody for diagnostic and therapeutic purposes | |
Weitz | A soluble protective antigen of Trypanosoma brucei | |
US4567041A (en) | Mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent | |
CA1337047C (en) | Gamma inulin compositions | |
Sharp et al. | Isolation and characterization of influenza virus B (Lee strain) | |
Mountain | Antibody production by spleen in vitro: I. Influence of cortisone and other chemicals | |
NL8104979A (nl) | Werkwijze voor de bereiding van immunobiologische preparaten, toe te passen bij de diagnose , het voorkomen en/of het behandelen van candida guilliermondii infecties. | |
Whang et al. | Inhibition by cardiolipin of the antibody response to bacterial antigens | |
CN108948185B (zh) | 蒜氨酸抗原及其免疫应答获得的家兔蒜氨酸抗体 | |
Vogel et al. | A microflocculation test for trichinosis | |
SU1750689A1 (ru) | Способ получени полисахаридно-белковой вакцины против NeISSeRIa меNINGIтIDIS серогруппы В | |
CN108948192B (zh) | 豚鼠免疫制备的蒜氨酸抗体 | |
CN112316132B (zh) | 一种姜黄素纳米脂质体佐剂及其制备方法 | |
RU2120300C1 (ru) | Способ получения эритроцитарного антигенного диагностикума | |
RU2188036C1 (ru) | Способ получения диагностикума эритроцитарного антигенного сапного | |
CA2171317C (en) | Method for purifying egg yolk immunoglobulins | |
CN101704870A (zh) | 戊二酰胆固醇及其脂质体和该脂质体作为疫苗佐剂的应用 | |
Barnhart et al. | Actively induced thrombocytopenia in the marmoset. A possible autoimmune model. | |
US3183161A (en) | Aqueous resuspension vaccine product of aluminum phosphate-adsorbed poliomyelitis virus antigen, and production process | |
SU1171038A1 (ru) | Способ диагностики туберкулеза | |
RU2111013C1 (ru) | Способ получения антител к арбовирусам комплекса калифорнийского энцефалита и батаи |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8009068-1 Effective date: 19920704 Format of ref document f/p: F |